I-MAK Challenges Validity of Remaining Hepatitis C Drug Patent in China
[Initiative for Medicines, Access & Knowledge press release, Link (CC-BY)] In a move that could strike down barriers to treatment for the exploding hepatitis C epidemic that kills 700,000 people every year, attorneys and scientists from the Initiative for Medicines,…
